Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Perrigo Holding from Gent, company number BE0431676229, closed financial year 2025 with a result of € 63.3 million after tax. For that financial year Perrigo Holding recorded revenue of € 48.4 million and equity of € 1.5 billion. Compared with financial year 2023, the result moved from € 33.3 million to € 63.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 1.5 billion
▲ 2% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 63.3 million
▲ 90% vs 2023
Profit after tax over the fiscal year.
€ 45 million paid out
71 % of the profit went to the shareholders, mostly to Perrigo Europe Invest NV (100 % of the shares). That is where the money ends up.
People and assets in 2025
37.7
▼ 1.2 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 11.2 million
▼ 23% vs 2023
€ 298,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3.3 million
▲ € 2.7 million vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 95 million
▼ 21% vs 2023
Loans from banks and other lenders, long and short.
€ 11.8 million
▼ 58% vs 2023
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 164 days on average.
€ 1.3 million
▼ 39% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 45,359,030 | € 33,603,955 | € 35,861,776 | € 48,351,635 | ▲ 35% |
| Profit after taxes | € 109,685,120 | € 1,063,774 | € 33,272,316 | € 63,327,800 | ▲ 90% |
| Equity | € 1,208,399,631 | € 1,493,623,867 | € 1,481,896,182 | € 1,507,634,968 | ▲ 2% |
| Total debts | € 369,425,991 | € 157,996,156 | € 183,602,460 | € 109,126,952 | ▼ 41% |
| Cash | € 1,376 | € 1,772 | € 1,746 | - | |
| Land & buildings | € 2,134,064 | € 2,045,316 | - | € 2,087,707 | |
| Retained profit | € 134,511,526 | € 135,575,300 | € 123,847,615 | € 149,586,401 | ▲ 21% |
| Dividend | € 96,000,000 | € 0 | € 45,000,000 | € 45,000,000 | |
| Bank debt | € 255,043,889 | € 115,420,763 | € 120,266,337 | € 95,000,000 | ▼ 21% |
| Balance sheet total | € 1,577,840,074 | € 1,651,634,475 | € 1,665,513,095 | € 1,617,102,148 | ▼ 3% |
| Employees (FTE) | 42.4 | 41.6 | 38.9 | 37.7 | ▼ 1.2 |
Key figures of Perrigo Holding, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Perrigo Holding?
What happened at Perrigo Holding in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jonas Dhaenens stepped down as director. NBB
- Sonia Hollies stepped down as director. NBB
- Magali Verbraecken stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 63.3 million (▲ 90% vs 2023). Source: NBB ↗
- Anja van Winsberghe stepped down as director. NBB
- Jonas Dhaenens became a director. NBB
- Sonia Hollies became a director. NBB
- Magali Verbraecken became a director. NBB
In short
From € 109.7 million profit in 2021 to € 63.3 million profit in 2025.
Paid € 1 million in corporate taxes since 2021.
Best year ever: 2021, with € 109.7 million profit.
Paid out € 186 million in dividends to the owners in total.
Management
The shares are held by Perrigo Europe Invest NV (100%). It owns 100% of Perrigo Schweiz AG, 100% of Perrigo Pharma Holding Nederland BV, 100% of Omega Pharma Innovation & Development, 46% of Omega Pharma AS, 44.9% of Perrigo Capital and 41.4% of Omega Pharma s.r.o. itself.
Directors
According to the 2025 annual accounts
Magali Verbraecken
Director
since 2023 · until 2029
Anja van Winsberghe
Director
Also active at: MEDGENIX BENELUX, OMEGA PHARMA TRADING, Perrigo Belgium, Perrigo Capital, Perrigo Europe Invest, Oce-Bio, JAICO R.D.P., HRA PHARMA BENELUX +2 more
since 2021 · until 2026
Jonas Dhaenens
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Capital, Perrigo Europe Invest, Oce-Bio, OMEGA PHARMA INTERNATIONAL, OMEGA PHARMA INNOVATION & DEVELOPMENT
since 2026 · until 2032
Sonia Hollies
Director
since 2024 · until 2030
Shareholders
Participations
Perrigo Schweiz AG
100%
Perrigo Pharma Holding Nederland BV
100%
Omega Pharma AS
46%
44.9%
Omega Pharma s.r.o.
41.4%
Omega Pharma Hellas SA
29.4%
Perrigo España SA
26%
Aco Hud Nordic AB
26%
Omega Pharma GmbH
26%
Perrigo Italia SrL
26%
Perrigo Poland Sp. Z. o.o.
25.7%
Perrigo România SRL
25.1%
Perrigo Bulgaria OOD
25%
Perrigo Portugal Lda
25%
20.1%
Establishments
Establishment units
Physical locations of this company
Gaston Crommenlaan 6 box 606
9050 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →OMEGA PHARMA TRADING same network
€ 538,596 revenue · 2025
Perrigo Belgium same network
€ 44.6 million revenue · 2025
Perrigo Capital same network
€ 2.2 million revenue · 2025
Perrigo Europe Invest same network
Oce-Bio same network
€ 4.1 million revenue · 2025
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0431.676.229
- VAT number
- BE 0431.676.229
- Registered office
- Gaston Crommenlaan 6 bus 606, 9050 Gent
- Names & denominations
- Perrigo Holding
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 July 1987
- Peppol
- Active · Active since 8 Dec 2025
- Activities · NACE
Activiteiten van holdings
Managementactiviteiten van holdings
Holdings